SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Human Genome Sciences, Inc. (HGSI) -- Ignore unavailable to you. Want to Upgrade?


To: Steven Rachbach who wrote (262)4/12/1999 5:09:00 PM
From: David Bogdanoff  Respond to of 1127
 
S:

I think that you picked a likely reason.

David



To: Steven Rachbach who wrote (262)4/12/1999 8:39:00 PM
From: RMP  Respond to of 1127
 
Or perhaps it has something to do with the American Association for Cancer Research (www.aacr.org) Annual Session. There appears to be a lot of discussion of biotechnology in general at this meeting. For example look at EntreMed (ENMD) today, and trace back the last few posts and related articles (Chicago Tribune, US News and World Report) on its SI thread.



To: Steven Rachbach who wrote (262)4/12/1999 10:39:00 PM
From: crete  Read Replies (1) | Respond to of 1127
 
Steven

I tend to believe you have probably answered your own question,however I've seen HGSI do this before.Both volume
and price on MLNM were up sharply,as well.I have exclaimed
my disappointment with the investment community in my recent
remarks,as they continue to reward companies like PRICELINE.COM,EBAY
AMAZON,etc., etc.,etc.and ignore HGSI and the extraordinary
implications of their science.

regards---ed
-